Browse by Glasgow Author (original) (raw)

Number of items: 4.

2025

Jaiswal, N. et al. (2025)Tranexamic acid in reducing expected blood loss in moderate to low risk surgeries: systematic review, meta-analysis and cost effectiveness analysis. medRxiv, (doi: 10.1101/2025.07.21.25331903)

2020

Xin, Yiqiao ORCID: https://orcid.org/0000-0001-5856-3103, Davies, Andrew, Briggs, Andrew ORCID: https://orcid.org/0000-0002-0777-1997, McCombie, Louise, Messow, C. Martina ORCID: https://orcid.org/0000-0003-0082-9946, Grieve, Eleanor ORCID: https://orcid.org/0000-0002-4115-2882, Leslie, Wilma S., Taylor, Roy and Lean, Michael E.J. ORCID: https://orcid.org/0000-0003-2216-0083(2020)Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)/Counterweight-Plus weight management programme. Diabetologia, 63, pp. 2112-2122. (doi: 10.1007/s00125-020-05224-2) (PMID:32776237) (PMCID:PMC7476973)

2019

Xin, Y. ORCID: https://orcid.org/0000-0001-5856-3103, Davies, A., McCombie, L., Briggs, A. ORCID: https://orcid.org/0000-0002-0777-1997, Messow, C.-M. ORCID: https://orcid.org/0000-0003-0082-9946, Grieve, E. ORCID: https://orcid.org/0000-0002-4115-2882, Leslie, W.S., Taylor, R. and Lean, M.E.J. ORCID: https://orcid.org/0000-0003-2216-0083(2019)Type 2 diabetes remission: economic evaluation of the DiRECT/Counterweight‐Plus weight management programme within a primary care randomized controlled trial. Diabetic Medicine, 36(8), pp. 1003-1012. (doi: 10.1111/dme.13981) (PMID:31026353)

Xin, Yiqiao ORCID: https://orcid.org/0000-0001-5856-3103, Davies, Andrew, McCombie, Louise, Briggs, Andrew ORCID: https://orcid.org/0000-0002-0777-1997, Messow, C.-Martina ORCID: https://orcid.org/0000-0003-0082-9946, Grieve, Eleanor ORCID: https://orcid.org/0000-0002-4115-2882, Leslie, Wilma S., Taylor, Roy and Lean, Michael E.J. ORCID: https://orcid.org/0000-0003-2216-0083(2019)Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes. Lancet Diabetes and Endocrinology, 7(3), pp. 169-172. (doi: 10.1016/S2213-8587(18)30346-2) (PMID:30581081)

This list was generated on Mon Feb 16 05:42:55 2026 GMT.